Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong · Delayed Price · Currency is HKD 4.390
+0.220 (5.28%)
Mar 6, 2026, 4:08 PM HKT
Lepu Biopharma Market Cap
Lepu Biopharma has a market cap or net worth of 7.92 billion as of March 6, 2026. Its market cap has increased by 67.18% in one year.
Market Cap
7.92B
Enterprise Value
8.30B
Revenue
767.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.39
Market Cap Chart
Since February 23, 2022, Lepu Biopharma's market cap has decreased from 11.84B to 7.92B, a decrease of -33.11%. That is a compound annual growth rate of -9.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.92B | -11.67% |
| Dec 31, 2025 | 8.97B | 100.10% |
| Dec 31, 2024 | 4.48B | -35.85% |
| Dec 29, 2023 | 6.99B | -42.72% |
| Dec 30, 2022 | 12.20B | 3.00% |
| Feb 23, 2022 | 11.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guangzhou Innogen Pharmaceutical Group | 10.18B |
| Shanghai Haohai Biological Technology | 9.98B |
| Nanjing Leads Biolabs | 9.95B |
| HBM Holdings | 9.58B |
| CStone Pharmaceuticals | 9.22B |
| CK Life Sciences Int'l., (Holdings) | 7.69B |
| Alphamab Oncology | 7.68B |
| Abbisko Cayman | 7.50B |